Comparing Apples to Broccoli
Pharmaceutical Executive
In late March, the Supreme Court debated the merits-or lack thereof-of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?
In late March, the Supreme Court debated the merits—or lack thereof—of the Obama Administration's Patient Protection and Affordable Care Act (ACA). The law's key provision, the individual mandate, sparked a proliferation of analogies from the Justices. Some of the analogies were helpful, some less so, but each one provided an insight into that particular Justice's thinking on the issue. Can you match the analogy with the Justice? (Hint: Two are from Justice Scalia)
Photo: Chip Somodevilla/Getty Images
Answers: A: Justice Scalia. B: Justice Breyer. C: Justice Sotomayor. D: Chief Justice Roberts. E: Justice Scalia.
Reshema Kemps-Polanco: Taking Risks for Greater Reward
May 14th 2025Reshema Kemps-Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of the Year, uses the lessons she learned from her family to bring out the best in her teams.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Novo Nordisk’s Sogroya Demonstrates Efficacy in Children with Growth Disorders
May 14th 2025Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.
